Nourishing Kidney Promoting Ovulation Decoction (NKPOD) Attenuates Polycystic Ovary Syndrome by Downregulating MiRNA-224

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2023 May 1

PMID 37123085

Authors

Yinhua Guo

Xingli Tong

Peipei Tang

Wenting Zuo

Yong Tan

Affiliations

Soon will be listed here.

Abstract

Background: Currently, exploring effective agents is urgently required for polycystic ovary syndrome (PCOS) treatment. Although nourishing kidney promoting ovulation decoction (NKPOD) as a traditional Chinese medicine decoction is widely employed to increase pregnancy rates, whether NKPOD attenuates ovulation disorders in PCOS patients remains unknown. Here, we aim to explore the clinical significance and the underlying mechanisms of NKPOD in ovulation disorders.

Methods: PCOS patients were recruited to confirm the clinical significance of NKPOD in attenuating ovulation disorder. Subsequently, regulation targets of NKPOD were identified through network pharmacology analysis. Additionally, a series of experiments were performed to observe the impacts of NKPOD on miRNA-224 transcription through transcription factor AR.

Results: In this study, NKPOD administration improved hormone dysregulation and reproductive outcomes in PCOS patients. Interestingly, 100 potential targets related to NKPOD and PCOS were screened, and transcription regulation was observed to be the most enriched function. Mechanistically, NKPOD inhibited miRNA-224 transcription through reducing AR expression, in which AR as a transcription factor directly regulated miRNA-224 transcription.

Conclusions: Collectively, these findings highlight the therapeutic effect of NKPOD on PCOS, which could provide promising therapeutic agents for PCOS.

References

Crespi B . Variation among human populations in endometriosis and PCOS A test of the inverse comorbidity model. Evol Med Public Health. 2021; 9(1):295-310. PMC: 8514856. DOI: 10.1093/emph/eoab029. View

Lite C, Ahmed S, Santosh W, Seetharaman B . Prenatal exposure to bisphenol-A altered miRNA-224 and protein expression of aromatase in ovarian granulosa cells concomitant with elevated serum estradiol levels in F adult offspring. J Biochem Mol Toxicol. 2019; 33(6):e22317. DOI: 10.1002/jbt.22317. View

Phylactou M, Clarke S, Patel B, Baggaley C, Jayasena C, Kelsey T . Clinical and biochemical discriminants between functional hypothalamic amenorrhoea (FHA) and polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf). 2020; 95(2):239-252. PMC: 11497304. DOI: 10.1111/cen.14402. View

Jiang N, Li X . The Disorders of Endometrial Receptivity in PCOS and Its Mechanisms. Reprod Sci. 2021; 29(9):2465-2476. DOI: 10.1007/s43032-021-00629-9. View

Artini P, Malacarne E, Tomatis V, Genazzani A . The relevance of inositols treatment for PCOS before and during ART. Eur Rev Med Pharmacol Sci. 2021; 25(14):4799-4809. DOI: 10.26355/eurrev_202107_26393. View

Lin Y, Xiang L, Li X, Tang Q, Meng F, Chen W . Exploring the Mechanism of Yi-Jing Decoction in Treating Polycystic Ovary Syndrome by Using Network Pharmacology. Curr Med Chem. 2022; 30(21):2463-2474. DOI: 10.2174/0929867329666220508180611. View

Zhang J, Xu W, Li S, Zhang J, Shang Y, Gui J . The role of miRNA-339-5p in the function of vascular endothelial progenitor cells in patients with PCOS. Reprod Biomed Online. 2022; 44(3):423-433. DOI: 10.1016/j.rbmo.2021.09.017. View

Zhao H, Xing C, Zhang J, He B . Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis. Reprod Health. 2021; 18(1):171. PMC: 8371888. DOI: 10.1186/s12978-021-01207-7. View

Kandasamy V, Balasundaram U . Caesalpinia bonduc (L.) Roxb. as a promising source of pharmacological compounds to treat Poly Cystic Ovary Syndrome (PCOS): A review. J Ethnopharmacol. 2021; 279:114375. DOI: 10.1016/j.jep.2021.114375. View

10.

Ren H, Shao Y, Ma X, An L, Liu Y, Wang Q . Interaction of circulating TGFβ regulatory miRNAs in different severity of diabetic kidney disease. Arch Physiol Biochem. 2022; 130(3):285-299. DOI: 10.1080/13813455.2022.2034884. View

11.

Jiang X, Yuan Y, Shi M, Zhang S, Sui M, Zhou H . Bu-shen-zhu-yun decoction inhibits granulosa cell apoptosis in rat polycystic ovary syndrome through estrogen receptor α-mediated PI3K/AKT/mTOR pathway. J Ethnopharmacol. 2021; 288:114862. DOI: 10.1016/j.jep.2021.114862. View

12.

Zhu P, Guan J, Hai Q, Jin J, Shi L, Hua L . The clinical effectiveness and safety of traditional Chinese medicine Jinfeng pill in adjuvant treatment of infertility with polycystic ovary syndrome: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2022; 101(4):e28676. PMC: 8797503. DOI: 10.1097/MD.0000000000028676. View

13.

Qin Y, Wang Y, Zhao H, Yang Z, Kang Y . Aberrant miRNA-mRNA regulatory network in polycystic ovary syndrome is associated with markers of insulin sensitivity and inflammation. Ann Transl Med. 2021; 9(18):1405. PMC: 8506717. DOI: 10.21037/atm-21-1288. View

14.

Liu X, Sun C, Zou K, Li C, Chen X, Gu H . Novel PGK1 determines SKP2-dependent AR stability and reprograms granular cell glucose metabolism facilitating ovulation dysfunction. EBioMedicine. 2020; 61:103058. PMC: 7581881. DOI: 10.1016/j.ebiom.2020.103058. View

15.

An F, Wu X, Zhang Y, Chen D, Lin Y, Wu F . miR-224 Regulates the Aggressiveness of Hepatoma Cells Through the IL-6/STAT3/SMAD4 Pathway. Turk J Gastroenterol. 2021; 32(6):532-542. PMC: 8975471. DOI: 10.5152/tjg.2021.191056. View

16.

Ozegowska K, Plewa S, Mantaj U, Pawelczyk L, Matysiak J . Serum Metabolomics in PCOS Women with Different Body Mass Index. J Clin Med. 2021; 10(13). PMC: 8268990. DOI: 10.3390/jcm10132811. View

17.

Jiang L, Huang J, Li L, Chen Y, Chen X, Zhao X . MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome. J Clin Endocrinol Metab. 2015; 100(5):E729-38. PMC: 4422895. DOI: 10.1210/jc.2014-3827. View

18.

Chen Y, Chai X, Zhao Y, Yang X, Zhong C, Feng Y . Investigation of the Mechanism of Zishen Yutai Pills on Polycystic Ovary Syndrome: A Network Pharmacology and Molecular Docking Approach. Evid Based Complement Alternat Med. 2021; 2021:6843828. PMC: 8702313. DOI: 10.1155/2021/6843828. View

19.

Gong Y, Wei X, Sun W, Ren X, Chen J, Aweya J . Exosomal miR-224 contributes to hemolymph microbiota homeostasis during bacterial infection in crustacean. PLoS Pathog. 2021; 17(8):e1009837. PMC: 8382196. DOI: 10.1371/journal.ppat.1009837. View

20.

Abdalla M, Deshmukh H, Atkin S, Sathyapalan T . miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A review. Life Sci. 2020; 259:118174. DOI: 10.1016/j.lfs.2020.118174. View